Prednisone can be appropriate during a COVID-19 infection, but only under specific circumstances. Current guidelines from the National Institutes of Health recommend corticosteroids, including prednisone, for hospitalized patients with moderate-to-severe COVID who need supplemental oxygen. For people with mild illness who are recovering at home, prednisone is generally not recommended because it suppresses the immune system at a stage when your body needs that immune response to fight the virus. The distinction between these scenarios is not a minor detail; getting it wrong in either direction can lead to real harm.
Why the Timing of Your Illness Matters So Much
COVID-19 tends to progress through two phases. In the first, the virus is actively replicating in your body. During this early window, your immune system is your main weapon, and dampening it with a steroid like prednisone can delay the time it takes to clear the virus. In the second phase, which happens in some patients about a week or so into the illness, the immune system can overcorrect and trigger widespread inflammation, sometimes called a cytokine storm. This excessive inflammation is what drives severe lung injury and acute respiratory distress syndrome.
Corticosteroids become valuable in that second phase because they dial down the runaway inflammatory response that is now causing more damage than the virus itself.1PubMed Central. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease This is why the blanket advice is not simply “yes” or “no” to prednisone with COVID. If you start steroids too early, you risk prolonging the infection. If you start them at the right moment during severe illness, they can reduce lung damage and lower the chance of dying.2PubMed Central. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent
Mild COVID at Home
If you have COVID but your symptoms are manageable and your oxygen levels are normal, reaching for prednisone is not advisable. The NIH guidelines specifically caution against corticosteroid use in non-severe cases because the risks outweigh the benefits. Suppressing your immune system while the virus is still actively replicating can slow recovery, open the door to bacterial infections, and paradoxically raise your chances of getting sicker.2PubMed Central. Corticosteroids for treatment of COVID-19: effect, evidence, expectation and extent
Some people assume that because steroids help with severe COVID, a short course might prevent mild COVID from becoming severe. The evidence does not support this. One study comparing inhaled corticosteroids and oral steroids in outpatients found that neither approach reduced the likelihood of developing persistent symptoms or the need for specialist referral afterward.3PubMed Central. Clinical Outcomes After Use of Inhaled Corticosteroids or Oral Steroids in a COVID-19 Telemedicine Clinic Cohort: Retrospective Chart Review In other words, taking steroids early “just in case” does not appear to give you a head start.
How Prednisone Compares to Other COVID Steroids
Most of the landmark COVID research used dexamethasone, not prednisone, which can cause some confusion. Dexamethasone is roughly seven times more potent per milligram than prednisone in anti-inflammatory effect and stays active in the body much longer, with a biological half-life of about 36 to 72 hours compared with 12 to 16 hours for prednisone.4Scientific Archives. Dexamethasone: The First Drug to be Shown to Decrease Mortality in Critically Ill Patients with COVID-19 Doctors sometimes substitute prednisone or other corticosteroids when dexamethasone is not available, when a patient cannot tolerate it, or when the clinical situation calls for a different dosing profile. The key point for patients is that these drugs belong to the same family and work through the same mechanism. Prednisone is not a lesser choice; it simply requires dose adjustment to match dexamethasone’s effect.
If You Already Take Prednisone for Another Condition
This is one of the trickiest situations, and the answer is straightforward: do not stop your steroid. If you take prednisone (or a related corticosteroid like hydrocortisone or prednisolone) for a condition such as adrenal insufficiency, lupus, inflammatory bowel disease, or severe asthma, abruptly stopping during a COVID infection could trigger an adrenal crisis on top of an acute illness. Your body has adapted to the external supply of cortisol, and yanking it away is dangerous.
For patients with adrenal insufficiency who develop COVID, expert guidance recommends increasing to stress-level dosing. Specifically, patients are advised to double their morning hydrocortisone dose immediately and then take 20 mg of hydrocortisone every six hours for the duration of the acute illness. Patients on prednisolone at a dose of 5 to 15 mg per day should increase to 10 mg every 12 hours.5PubMed Central. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency If there is clinical deterioration, the recommendation shifts to an immediate intramuscular injection of 100 mg hydrocortisone, followed by continuous intravenous dosing.6European Journal of Endocrinology. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
There is a catch worth knowing about: long-term glucocorticoid use itself may worsen COVID outcomes. Research suggests that chronic steroid use can increase COVID-related mortality and may even cause the adrenal glands to stop producing cortisol on their own, a condition called iatrogenic adrenal insufficiency.7PubMed Central. COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders This does not mean you should lower or stop your dose without medical guidance. It means your care team should be monitoring you more closely if you catch COVID while on chronic steroids.
Risks of Steroid Use During COVID
The side effects of corticosteroids are well established outside the COVID context, but the combination of steroids and a SARS-CoV-2 infection creates some specific problems that deserve attention.
Blood Sugar Spikes
Prednisone and related steroids reliably raise blood glucose. In COVID patients, this has led to a marked increase in hyperglycemia and its dangerous complications, including diabetic ketoacidosis. India’s Endocrine Society issued a formal position statement on managing steroid-related high blood sugar during COVID because the problem became so widespread.8PubMed Central. Diagnosis and Management Considerations in Steroid-Related Hyperglycemia in COVID-19: A Position Statement from the Endocrine Society of India If you have diabetes or prediabetes, your blood sugar will almost certainly climb during a steroid course, and you should have a plan with your doctor for more frequent monitoring and possible insulin adjustments.
Fungal Infections
The surge in mucormycosis (sometimes called “black fungus”) during COVID waves in parts of the world was driven in large part by the combination of steroid-suppressed immune systems and elevated blood sugar. Patients undergoing corticosteroid therapy were found to be highly susceptible to this severe fungal infection, particularly when they also had diabetes or other conditions that compromised their immune defenses.9PubMed Central. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review Among critically ill COVID patients on ventilators, one study found that dexamethasone use was associated with roughly a fourfold increase in the odds of developing a secondary infection, and invasive fungal infections occurred only in patients who had received dexamethasone.10PubMed Central. Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation
Psychiatric Effects
Steroids can cause mood swings, insomnia, anxiety, and in some cases more serious psychiatric symptoms like psychosis or mania. Researchers have argued that the incidence of these side effects may be higher in COVID patients than in typical steroid users, possibly because the virus itself affects the brain and nervous system. Any new-onset psychiatric symptoms during or after a COVID steroid course should be flagged to a doctor rather than dismissed as general illness malaise.
The Rebound Problem When Steroids Stop
Stopping corticosteroids too quickly after a course for COVID pneumonia can cause inflammation to flare back up, sometimes worse than before treatment began. This “rebound” phenomenon has been documented in case reports and small series. In one case of severe COVID pneumonia, a 38-year-old patient experienced significant worsening of lung inflammation after dexamethasone was discontinued, underscoring the need to tailor both the timing and the length of steroid treatment to the individual rather than applying a rigid protocol.11PubMed Central. A Case of Rebound Inflammation in a 38-Year-Old Man with Severe COVID-19 Pneumonia Following Cessation of Dexamethasone Therapy
A broader review of post-steroid rebound in COVID pneumonia concluded that clinicians should maintain a low threshold for slow steroid tapers rather than the standard short-course approach, which in the UK has typically been ten days or less of dexamethasone. The authors emphasized that monitoring lung function during the taper is important to catch rebound inflammation early and avoid long-term scarring of lung tissue.12PubMed Central. Post-steroid rebound in COVID-19 pneumonitis: a case series and review of the literature If your doctor prescribes a steroid for COVID, ask specifically about the tapering plan rather than assuming you will simply stop after a set number of days.
Pregnant Women and Children
Pregnancy adds complexity because dexamethasone crosses the placenta more readily than some alternatives. The Royal College of Obstetricians and Gynaecologists recommends that pregnant women with moderate-to-severe COVID receive oral prednisolone or intravenous hydrocortisone rather than dexamethasone, partly to reduce fetal exposure while still treating the mother’s inflammation.13PubMed Central. Corticosteroids Use in Pregnant Women with COVID-19: Recommendations from Available Evidence This is one of the few clinical situations where prednisone (or its active form prednisolone) is actually preferred over dexamethasone for COVID.
In children, the main COVID-related steroid discussion centers on a rare but serious complication called PIMS-TS (or MIS-C in the United States), a multisystem inflammatory syndrome that appears weeks after infection. A large trial found moderate evidence that intravenous methylprednisolone reduced the duration of hospital stay for these children compared with usual care.14The Lancet Child & Adolescent Health. Methylprednisolone, intravenous immunoglobulin, tocilizumab, or anakinra for children and young people with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 For children with routine COVID symptoms who are not hospitalized, the same general principle applies as for adults: steroids are not recommended for mild illness.
Asthma and COVID
People with asthma who catch COVID face a unique dilemma. Systemic corticosteroids are the standard treatment for asthma flare-ups, and many asthma patients have used prednisone during exacerbations for years. Early in the pandemic, there was concern that giving steroids to asthmatics with COVID could worsen the viral infection. Research has since suggested the opposite may be true in this population. Asthma involves a specific type of inflammation (called type 2 inflammation) that actually impairs the body’s antiviral defenses. Corticosteroids suppress that type 2 response, which may restore the antiviral pathways that asthma had been blocking.15PubMed Central. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used? In practice, this means a person with asthma who develops a flare triggered by COVID should not avoid their usual steroid treatment out of fear. The decision should still involve their doctor, but the risk-benefit calculation tilts differently for asthmatics than for the general population with mild COVID.
Steroids and COVID Vaccine Response
If you are on prednisone or another corticosteroid, you might wonder whether the medication affects how well COVID vaccines work for you. Research on patients with autoimmune diseases found that those on high-dose, long-term steroid treatment had a significantly weaker T-cell response to a third dose of an mRNA COVID vaccine compared with patients on low doses or no steroids.16Scientific Reports. Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients Interestingly, antibody levels remained adequate in most patients regardless of steroid dose, so the blunting was more apparent in the cellular arm of the immune response.
A separate review reported that prednisone use was associated with a roughly tenfold reduction in antibody levels after vaccination, independent of the daily dose.17The Lancet Rheumatology. Immunomodulatory therapies and COVID-19: a review These two findings paint slightly different pictures, likely because the studies looked at different patient populations and different timing of measurements. The practical takeaway is that if you take prednisone regularly, your vaccine protection may be somewhat reduced, and you should discuss booster timing and additional precautions with your doctor rather than assuming you are fully protected after the standard schedule.
Steroids for Long COVID Symptoms
Some patients deal with lingering symptoms for weeks or months after clearing the initial infection, a condition broadly called long COVID. A subset of these patients, particularly those with ongoing lung inflammation visible on imaging, appear to benefit from corticosteroids. One observational study treated 30 patients who had persistent post-COVID interstitial lung disease with prednisolone. All 30 reported significant improvement in breathlessness and function, with lung transfer factor increasing by about a third on average and forced vital capacity improving meaningfully as well.18Annals of the American Thoracic Society. Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment
A separate small study gave eight long COVID patients a four-day course of prednisone at 30 mg per day and found that joint pain, muscle pain, and fatigue were the symptoms most likely to improve. One patient recovered completely from all symptoms after the short course.19PubMed Central. A Short Corticosteroid Course Reduces Symptoms and Immunological Alterations Underlying Long-COVID Another evaluation used a longer steroid taper of eight to ten weeks in long COVID patients who had abnormal lung scans along with low oxygen levels. About 86% of patients with the most severe breathlessness improved substantially, and a quarter of those with abnormal scans had completely normal scans after treatment. The authors cautioned, however, that the immunosuppressive effects of steroids raise concerns in regions where infections like tuberculosis are common.20Monaldi Archives for Chest Disease. Systemic corticosteroids for management of ‘long-COVID’: an evaluation after 3 months of treatment
These results are encouraging for a specific slice of long COVID patients, mainly those with demonstrable lung inflammation. Steroids are not a blanket treatment for all long COVID symptoms, and the studies so far have been small and observational. If your main long COVID symptoms are fatigue or brain fog without evidence of active lung disease, a steroid trial is less clearly justified and carries the usual risks of immune suppression, blood sugar disruption, and bone thinning with longer courses.
Drug Interactions With COVID Antivirals
If you take prednisone and are prescribed Paxlovid (nirmatrelvir/ritonavir) for an acute COVID infection, the interaction deserves attention. Ritonavir, one of the two components in Paxlovid, is a potent inhibitor of the liver enzyme that metabolizes many drugs, including corticosteroids. This means that taking your usual prednisone dose alongside Paxlovid could effectively amplify the steroid’s effect, because your body clears it more slowly. The result can be an unintentional overdose of corticosteroid activity, with exaggerated side effects like elevated blood sugar, fluid retention, and immune suppression. Your prescribing doctor or pharmacist should adjust your prednisone dose or monitor you more closely during the five-day Paxlovid course. This is not something to sort out on your own; flag the combination proactively when picking up either prescription.